Back to search
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Extrahepatic Bile Duct Adenocarcinoma, Biliary Type trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Extrahepatic Bile Duct Adenocarcinoma, Biliary Type trials you may qualify forThis international, multicenter, open-label randomized controlled trial evaluates whether repeated endobiliary radiofrequency ablation (EB-RFA) improves overall…
Diagnosis of extrahepatic cholangiocarcinoma is challenging because the yield of imaging and tissue sampling is limited. Raman spectroscopy is an optical method…
The diagnosis of malignant biliary strictures remains a challenging aspect of biliary endoscopy. Molecular biological testing techniques based on bile have been…
A median survival period of 3 to 6 months is the prognosis for patients with advanced, unresectable EHCC. For patients with locally advanced, unresectable EHCC,…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
Purpose of the Study: Bile duct cancers are rare and aggressive. About 250 new cases are diagnosed each year in Denmark. These cancers are difficult to detect…
This phase III trial studies how well gemcitabine hydrochloride and cisplatin given with or without nab-paclitaxel work in treating patients with newly diagnose…